Find a Trial

Trial Summary


Protocol No.CTO-208887
StatusOPEN TO ACCRUAL
Principal InvestigatorSuvannasankha, Attaya
ScopeNational
PhasePhase I/II
Age GroupAdult
TitleA Phase I/II Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM5
Applicable Disease SitesMultiple Myeloma
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu